155 related articles for article (PubMed ID: 12780519)
1. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
Salmenkivi K; Heikkilä P; Liu J; Haglund C; Arola J
APMIS; 2003 Apr; 111(4):458-64. PubMed ID: 12780519
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
Favier J; Plouin PF; Corvol P; Gasc JM
Am J Pathol; 2002 Oct; 161(4):1235-46. PubMed ID: 12368197
[TBL] [Abstract][Full Text] [Related]
3. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
5. Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri AI; Heikkilä P; Liu J
J Clin Endocrinol Metab; 2001 May; 86(5):2231-5. PubMed ID: 11344232
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.
Salmenkivi K; Haglund C; Ristimäki A; Arola J; Heikkilä P
J Clin Endocrinol Metab; 2001 Nov; 86(11):5615-9. PubMed ID: 11701743
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor in canine mammary tumors.
Restucci B; Papparella S; Maiolino P; De Vico G
Vet Pathol; 2002 Jul; 39(4):488-93. PubMed ID: 12126152
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of tenascin in pheochromocytomas correlates with malignancy.
Salmenkivi K; Haglund C; Arola J; Heikkilä P
Am J Surg Pathol; 2001 Nov; 25(11):1419-23. PubMed ID: 11684959
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.
Joo YE; Rew JS; Seo YH; Choi SK; Kim YJ; Park CS; Kim SJ
J Clin Gastroenterol; 2003 Jul; 37(1):28-33. PubMed ID: 12811205
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
Qi SY
Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
[TBL] [Abstract][Full Text] [Related]
12. The significance of angiogenesis in malignant pheochromocytomas.
Rooijens PP; de Krijger RR; Bonjer HJ; van der Ham F; Nigg AL; Bruining HA; Lamberts SW; van der Harst E
Endocr Pathol; 2004; 15(1):39-45. PubMed ID: 15067175
[TBL] [Abstract][Full Text] [Related]
13. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.
Viglietto G; Romano A; Maglione D; Rambaldi M; Paoletti I; Lago CT; Califano D; Monaco C; Mineo A; Santelli G; Manzo G; Botti G; Chiappetta G; Persico MG
Oncogene; 1996 Aug; 13(3):577-87. PubMed ID: 8760299
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and its cognate receptors in human pheochromocytomas.
Takekoshi K; Isobe K; Yashiro T; Hara H; Ishii K; Kawakami Y; Nakai T; Okuda Y
Life Sci; 2004 Jan; 74(7):863-71. PubMed ID: 14659975
[TBL] [Abstract][Full Text] [Related]
15. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
16. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
Lewy-Trenda I; Wierzchniewska-Ławska A
Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
[TBL] [Abstract][Full Text] [Related]
18. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
19. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
20. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]